Canntab Therapeutics Limited
CTABF
$0.00
$0.000.00%
OTC PK
| 02/28/2023 | 11/30/2022 | 08/31/2022 | 05/31/2022 | 02/28/2022 | |
|---|---|---|---|---|---|
| Net Income | -305.90K | -764.60K | -362.90K | -1.14M | -329.10K |
| Total Depreciation and Amortization | 67.80K | 127.40K | 107.80K | 148.40K | 85.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 167.80K | 402.60K | -32.00K | 410.80K | -226.00K |
| Change in Net Operating Assets | 42.30K | 192.20K | -121.80K | -35.90K | -128.40K |
| Cash from Operations | -27.90K | -42.50K | -408.80K | -613.00K | -597.70K |
| Capital Expenditure | -- | -- | -- | 0.00 | 300.00 |
| Sale of Property, Plant, and Equipment | -- | -- | -- | 0.00 | 188.40K |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2.10K | -9.20K | -- | -10.40K | -16.50K |
| Cash from Investing | -2.10K | -9.20K | -- | -10.40K | 172.20K |
| Total Debt Issued | -- | -- | -- | 0.00 | 1.30M |
| Total Debt Repaid | 2.00K | -20.10K | -18.90K | -17.70K | -16.50K |
| Issuance of Common Stock | -- | -- | -- | 0.00 | 427.10K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.50K | -14.90K | -14.70K | -13.90K | 1.35M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -28.50K | -66.70K | -423.50K | -637.30K | 920.00K |